News
Vizgen Secures $37M Series B Financing to Advance Spatial Genomics Through Commercialization of MERSCOPE™ Platform
Read MoreNature Methods Cites Vizgen’s Spatial Genomics Technology in Method of the Year 2020 Feature
Read MoreVizgen to Launch Early Release Program for Proprietary Spatial Genomics Technology
Read MoreVizgen Launches with $14M Series A Financing Led by ARCH Venture Partners and Northpond Ventures
Read More
Synbiobeta
Visualizing the Future: Spacialomics Transforms Study of Gene Expression
Read MoreBio-IT World
Spatial Surge: AGBT Updates On Single-Cell and Spatial Genomics, In Situ Analysis, More
Read MoreThe Science Advisory Board
Vizgen launches integrated Merscope in situ imaging platform
Read MoreNature Methods: Comment
Spatially resolved single-cell genomics and transcriptomics by imaging
Read MoreNature Methods: Technology Feature
Method of the Year: spatially resolved transcriptomics
Read MoreGenomeWeb
Vizgen Plans Launch of Spatial Transcriptomics Platform Based on MERFISH Technology
Read MoreEndpoints News
Striving for higher res imaging of cells, Harvard team debuts startup with backing from ARCH, Northpond
Read MoreBioCentury
Arch Thinks Vizgen’s Technology Could Improve Transcriptome Imaging, Provide More Insight Into Disease Biology
Read MoreMedia Contact:
To speak with a Vizgen Company
Representative about Vizgen and MERFISH,
please send email inquiry to:
media@vizgen.com
